APA (7th ed.) Citation

G, A., F, D., U, R., A, U., H, U., IA, K., . . . M, D. (2026). Corrigendum to in vivo effects of a selected thiourea derivative 1-(2-chlorobenzoyl)-3-(2,3-dichlorophenyl) against nociception, inflammation and gastric ulcerogenicity: Biochemical, histopathological and in silico approaches [Biomed. Pharmacother. 174 (2024) 116544]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 119602. https://doi.org/10.1016/j.biopha.2026.119602

Chicago Style (17th ed.) Citation

G, Ali, et al. "Corrigendum to in Vivo Effects of a Selected Thiourea Derivative 1-(2-chlorobenzoyl)-3-(2,3-dichlorophenyl) Against Nociception, Inflammation and Gastric Ulcerogenicity: Biochemical, Histopathological and in Silico Approaches [Biomed. Pharmacother. 174 (2024) 116544]." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 2026: 119602. https://doi.org/10.1016/j.biopha.2026.119602.

MLA (9th ed.) Citation

G, Ali, et al. "Corrigendum to in Vivo Effects of a Selected Thiourea Derivative 1-(2-chlorobenzoyl)-3-(2,3-dichlorophenyl) Against Nociception, Inflammation and Gastric Ulcerogenicity: Biochemical, Histopathological and in Silico Approaches [Biomed. Pharmacother. 174 (2024) 116544]." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2026, p. 119602, https://doi.org/10.1016/j.biopha.2026.119602.